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Recent studies showed that IL-22 plays a protective role in the host defense. However, the contribution of
polymorphisms of the IL-22 gene to human TB susceptibility remains untested. We have designed a
computational approach to select functional SNPs in the IL-22 gene and genotyped them in a two-stage
case-control study in Chinese (479 cases and 358 controls). We found that rs2227473, an SNP in the
promoter region of IL-22, is associated with TB susceptibility at both stages of our study. The SNP shows
associations with p-values of 0.028 and 0.034 respectively, and a combined p-value of 0.0086, with odds ratio
at 0.65 (95% confidence interval 0.45–0.90). We further validated the association with an independent
cohort (413 cases and 241 controls in Chinese). Our functional studies showed that patients with A allele
have significantly higher IL-22 expression than those without A allele under both non-specific and specific
stimulations.
T
uberculosis (TB), caused byMycobacterium tuberculosis infection, is an infectious disease that is reemerging
as amajor killer of humans. It has been estimated that one third of the world’s population are infected by TB,
with more than nine million becoming sick each year with ‘‘active’’ TB, which can be spread to healthy
people1. Most people infected with Mycobacterium tuberculosis do not develop active diseases, a status called
‘‘latent tuberculosis infection (LTBI)’’; only 5–10% eventually develop active tuberculosis diseases, indicating that
host response plays a critical role in containment of TB infection. Indeed, both animal and clinical studies have
demonstrated that cellular immunity, particularly the CD41 T cell immunity, plays indispensable roles in
protective immune responses against TB infection2.
So far, a large number of polymorphisms in the human leucocyte antigens (HLA) have been discovered to be
associated with TB susceptibility in a wide range of ethnic populations3. The variations in cytokines and their
receptors have also been shown to influence susceptibility to TB. For example, A874T polymorphism in the first
intron of interferon (IFN)-c gene was reported to be associated with TB susceptibility in Sicilians4, South
Africans5, and Chinese6. Other cytokines, such as IL-1, IL-2, IL-4, IL6, IL-10, IL-12, TNF-a, and TGF-b, have
also been associated with TB3. A recent genome wide association study identified a single nucleotide polymorph-
ism (SNP) in the gene desert region of 18q11.2 that was associated with tuberculosis with p-value of 6.831029 in
Ghana and Gambia populations7.
It was recently reported that IL-17 and IL-22, produced by T helper type 17 (Th17) cells and NK cells, play
important roles in TB protective immune response8,9. In vitro experiments showed that IL-22 can directly affect
human macrophages, improving cells’ protective immunity against TB infection10. IL-22 has also been shown to
induce host defense genes, and thus is crucial for controlling the gram-negative pulmonary pathogen, Klebsiella
pheumaniae11. Knock-out study observed that IL-22 null mice showed increased intestinal epithelial damage,
systemic bacterial burden and mortality after Citrobacter rodentium infection12. It was also reported that IL-22
can inhibit intracellular mycobacterial growth by enhancing phagolysosomal fusion, which contributes to the
immune defenses of NK cells against M. tuberculosis10.
We thus hypothesize that the genetic variations in the IL-22 gene among humans play an important role in TB
susceptibility. Based on our previous study13, we are interested in the SNPs in the IL-22 gene region that could
affect TB susceptibility, particularly the SNPs that could affect the regulation of this gene. To address this
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hypothesis, we carried out extensive genotyping experiments in the
gene and evaluated their relationship with TB susceptibility.
We adopted a two-stage approach to genotype the selected SNPs
for the experimental cohort, and further validated our discovery in a
validation cohort. In the first stage, we scanned a relatively large
number of SNPs in a limited number of samples to identify the
markers with potential interest. We then selected a small number
of SNPs that showed promise, and typed them in a large number of
independent samples. The two-stage scan has been adopted in many
genome-wide association studies and has been shown to be effective.
In this study, during the first stage, we typed 48 cases and 48 controls,
which were randomly selected from the pools. We then selected 6
SNPs that met our selection criteria and typed the remaining 431
cases and 310 controls.We finally genotyped one SNP (rs2227473) in
the independent validation cohort (413 cases and 241 controls) to
further confirm our study. The biological functions (target gene
IL-22’s expression) of different genotypes under specific and non-
specific stimulations were investigated and compared.
Results
Reduced susceptibility of the rs2227473A allele in patients with
TB in stage I data. In stage I of 48 cases and 48 controls, the
rs2227473 marker, which is located in -1756 bp upstream of the
IL-22 gene transcription start site (TSS), was in Hardy-Weinberg
equilibrium. The minor allele frequency of 0.103 in the control is
comparable to the annotations in the HapMap (0.102 for CHB1JPT,
0.120 for YRI, and 0.208 for CEU). The ‘A’ allele is associated with
decreased risk of TB susceptibility at p-value of 0.0275, with odds
ratio (OR) of 0.188 (confidence interval (CI) 5 0.037–0.967), as
shown in Table 1. The haplotype analysis was further performed
in the surrounding region of this SNP. We found that the
haplotype TCATGA—which is made of SNPs rs2227485,
rs2227484, rs2227483, rs2227478, rs2227473, and rs2227472—
shows a trend of association with decreased risk of TB
susceptibility at p-value of 4.89E-5 (Supplementary Table S1). We
therefore selected these 6 SNPs for genotyping in the second stage.
Reduced susceptibility of the rs2227473A allele in patients with
TB in stage II and pooled data. The association of rs2227473 was
confirmed in the stage II experimental dataset with 431 cases and 310
controls. As shown in Table 1, the association is significant at a p-
value of 0.0343, with OR 5 0.694 (95% CI 5 0.494–0.975). Analysis
on the pooled data (479 cases and 358 controls) showed even more
significant association at a p-value of 0.0086, with OR50.653 (95%
CI50.449–0.896). This SNP was predicted to alter the protein-DNA
interactions among several transcription factors (TFs), including
three TFs from the UniPROBE database, and two TFs from the
Jaspar database (Supplementary Table S2).
Marginal association between rs2227473 and TB in validation
cohort. The association was further validated by an independent
cohort with 413 cases and 241 controls, which were collected after
Feb., 2010 (Table 1). The association was marginally significant in
this dataset, with p-value of 0.061, OR50.702 (95% CI50.484–
1.107). However, when we combined the experimental and
validation cohorts, the association was very significant at a p-value
of 0.001 (OR50.663, with 95% CI50.518–0.847).
Effects of rs2227473 genotypes on IL-22’s protein expression. To
test whether different genotypes of the rs2227473 affect IL-22’s
expression levels, we stimulated patients’ peripheral blood
mononuclear cells (PBMCs) with both anti-CD3/anti-CD28
antigene nonspecific and Mtb antigen-specific stimulations.
Patients with A allele (GA1AA, n529) at rs2227473 had
significantly higher IL-22 protein productions than those without
A allele (GG, n529) under both non-specific (p value 50.0095)
and specific stimulations (p value 5 0.0099, Figure 1).
Other polymorphisms in the IL-22 promoter region that reduce
the susceptibility of TB in stage II and pooled data. Among the
other five SNPs we genotyped in stage II of the experimental cohort,
four of them showed significant association with TB susceptibility
(Table 2). The locations of the four SNPs to the IL-22 TSS are
rs2227472 (-1851bp), rs2227478 (-1340bp), rs2227483 (-894bp),
Table 1 | The association of TB susceptibility and the rs2227473 marker in the promoter region of IL-22 in multiple stages of association
studies in Chinese.
Cohort Stage
Sample counts MAF
Minor allele OR
95% CI*
P-value{Cases Controls Cases Controls LCL UCL
Experimental I 48 48 0.021 0.103 A 0.188 0.037 0.967 0.0275
II 431 310 0.107 0.148 A 0.694 0.494 0.975 0.0343
I1II Combined 479 358 0.098 0.144 A 0.653 0.449 0.896 0.0086
Validation - 413 241 0.086 0.114 A 0.702 0.484 1.107 0.061
E1V Combined - 892 599 0.092 0.132 A 0.663 0.518 0.847 0.001
*95% CI; lower and upper confidence limits. {Allelic p-value.
Figure 1 | IL-22 production by PBMCs from individuals with polymorphism in IL-22 (rs2227473). Subjects were grouped for SNP (rs2227473) in IL-22
as genotype with (GA1AA, n529) or without (GG, n529) A allele. Frozen PBMCs were thawed and cultured for 96 hours in the presence of anti-CD3/
anti-CD28 (1mg/ml each), or killed Mtb. (20mg/ml). Supernatant was collected and the concentration of IL-22 was determined by ELISA. IL-22 protein
production by PBMC in response to (A) anti-CD3/anti-CD28 and (B) Mtb. Data are represented as mean 6 SEM. P values are indicated.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 1 : 20 | DOI: 10.1038/srep00020 2
and rs2227485 (-431bp). SNP rs2227472 is 95 bp upstream of our
major SNP, rs2227473. Its A allele is a major allele in controls, but a
minor allele in cases in both stage II and pooled data. Similar patterns
were observed for two other SNPs, rs2227478 and rs2227485, which
are 416 bp, and 1325 bp downstream of rs2227473, respectively. All
the four SNPs have p-values in the range of 0.021–0.044, with OR
range from 0.74–0.80 (Table 2) for the stage II data. Similar results
were observed for the pooled data.
Haplotypes in the IL-22 promoter region that affect the
susceptibility of TB in pooled data. We observed very high
linkage disequilibrium among the five SNPs in the control
population of the pooled data (Figure 2). We thus performed the
association study between the haplotypes of these five SNPs and TB
susceptibility. As shown in Table 3, haplotype CTTAA (SNPs in the
order of rs2227485, rs2227483, rs2227478, rs2227473, and
rs2227472) shows very strong association with decreased TB
susceptibility, at p-value of 2.12E-6, with OR at 0.04 (95%
CI50.01–0.35). On the other hand, the haplotype TATGG, which
consists of all major alleles, shows significant association with
increased TB susceptibility at p-value of 0.01, with OR at 1.49
(95% CI51.05–2.13). In the pooled data of the two stages, the p-
value is slightly more significant for rs2227478, and a bit less
significant for rs2227472, when comparing with stage II alone. The
linkage disequilibriums (LDs) of the five SNPs are given in Figure 2,
showing moderate LDs.
The association between SNPs in the IL-22 promoter region and
TB susceptibility in pooled data stratified by age at diagnosis
(#25 and .25). We further stratified our pooled data according
to the age when the patients were admitted to the hospital for the
experimental cohort. As shown in Table 4, out of five SNPs showing
significant association in the pooled data, three SNPs (rs2227472,
rs2227483, and rs2227485) showed more significant association in
younger patients but not in elder patients, and two other SNPs
(rs2227473 and rs2227478) showed significant association in elder
patients but not in younger patients. Notably SNP rs2227485, which
is marginally significant in the pooled data (p-value 5 0.049),
showed very significant association with decreased TB
susceptibility in younger patients (age ,525 years old) at p-value
of 5.2E-5, with OR 5 0.496 (95% CI50.303–0.663). But for the older
group (age .25), this SNP did not show any association with TB
susceptibility. A similar situation is true for SNP rs2227472.
Discussion
IL-22 has been reported to play a role in host defense against bacterial
pathogens11. It is involved in host defense at environmental inter-
faces, such as mucosal surfaces of the airways and gastrointestinal
tract. IL-22 can activate STAT3, which is a transcription activator
that mediates the expression of a variety of genes in response to
various cytokines14. It regulates genes that are involved in antimicro-
bial defense and cellular differentiation15. IL-22 can restrict the
growth of M. tuberculosis in macrophages by enhancing phagolyso-
somal fusion10. However, the associations between genetic variations
in the IL-22 gene and its promoter region and TB susceptibility have
never been reported. In this study, we carried out this association
study between the IL-22 gene, and found several SNPs in the IL-22
promoter region that influence TB susceptibility.
Our approach of SNP selection is different from the traditional
way of tagging SNPs, where SNPs were usually selected based only on
the linkage disequilibrium in a genomic region. The SNP selection
process focuses more on efficiency, which maximizes the coverage
but minimizes the cost (the number of SNPs for genotyping)16. After
genotyping, one can search for the functional SNPs with close LD
to the tagged SNP that shows significant associations, as we did
previously in breast cancer scanning17. However, there are disadvan-
tages of this approach. (1) The LD is usually inferred from a limited
number of previously genotyped data, such as HapMap. It might be
different in the current studied population. (2) It ignores the func-
tional role of the SNP, and many tagged SNPs are in the gene desert
regions, and have little biological meanings18,19. Our SNP selection
approach focuses on the functional role of the SNPs, particularly in
the promoter region of the gene that might affect the transcription
factor binding sites. We found this simple approach very effective in
identifying functional SNPs for our IL22 promoter study. Among the
Table 2 | The association of TB susceptibility and polymorphism of four SNPs in the promoter region of IL-22 in the second stage and two
stages pooled studies in Chinese.
Stage
Sample counts
SNP id
MAF
Minor allele OR
95% CI
P-valueCases Controls Cases Controls LCL UCL
II 431 310 rs2227472 0.464 0.526 A 0.778 0.621 0.974 0.0285
rs2227478 0.148 0.189 C 0.746 0.564 0.988 0.0405
rs2227483 0.458 0.534 A 0.739 0.573 0.955 0.0205
rs2227485 0.467 0.523 C 0.798 0.641 0.993 0.0432
I1II (pooled) 479 358 rs2227472 0.465 0.522 A 0.796 0.646 0.981 0.0323
rs2227478 0.148 0.191 C 0.769 0.592 0.957 0.0220
rs2227483 0.46 0.528 T 0.762 0.604 0.962 0.0223
rs2227485 0.466 0.517 C 0.816 0.665 1.000 0.0499
Figure 2 | Pattern of linkage disequilibrium across the IL22 promoter
region in the pooled Chinese population. The LD pattern is represented
by pairwise D’ values between SNPs based on genotypes from the pooled
study of 479 cases and 358 controls. D’ values (3100) for each comparison
are given in the squares. Empty squares represent D’ values equal to 1.
www.nature.com/scientificreports
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thirteen regulatory SNPs we selected, five (38.5%) showed significant
association with TB susceptibility. This number is very high com-
pared with non-regulatory SNPs, of which we selected seven SNPs,
with none of them showing significant association. However, the
effectiveness of this approach on other genes is unknown and yet
to be tested.
The SNPs we found are biologically meaningful. The SNP
rs2227473 alters the putative binding sites of several transcription
factors from multiple databases, including Cgd2_3490 and
PF14_0633, from the UniPROBE database, and RCGCANGCGY,
and TCCCRNNRTG from the Jaspar database. Both Cgd2_3490
and PF14_0633 are hypothetical transcription factors containing
AP2 domain. Cgd2_3490 is from Cryptosporidium parvum20,21 and
PF14_0633 is from Plasmodium falciparum22,23,24. We propose that
the two proteins from pathogens can target the host genes and regu-
late IL-22’s expression. The variations in the binding sites of the two
proteins provide a differential way of regulation. The two motifs,
RCGCANGCGY and TCCCRNNRTG, were discovered by scanning
the promoters of all human genes for conserved motifs25.
RCGCANGCGY matches the binding consensus of transcription
factor NRF1 (nuclear respiratory factor 1), which binds to the cyto-
chrome c promotor26, and is essential for cell survival in oxidative
stress inducing agents27.
Consistent with previous research that patients with tuberculosis
have significantly lower Th22 response than healthy donors28, our
functional assay indicated that PBMCs from individuals carrying
rs2227473G allele in IL-22, which is associated with susceptibility
to tuberculosis, produce significantly lower IL-22 in response to
polyclonal and Mtb antigen stimulation. Although we are currently
uncertain with the mechanism of predisposition to tuberculosis in
individuals with the rs2227473G allele, it probably lies at the level of
the macrophage as well as lung epithelial cell. The macrophage is not
only the most important effector of immunity to kill infected
Mycobacterium tuberculosis, but also the niche to host them. It
has been well recognized that Mycobacterium tuberculosis resides
in phagosomes within macrophages, and killing these mycobacteria
tuberculosis requires fusion of the phagosome with a lysosome.
Importantly, Dhiman et al demonstrated that human IL-22 inhibits
growth of mycobacterium tuberculosis by enhancing phagolysoso-
mal fusion10.While there is no evidence to show the effect of IL-22 on
epithelial cells to kill Mycobacterium tuberculosis, IL-22 has been
known to enhance lung epithelial cells to produce b-defensin15,29,
which is beneficial to clear infected Mycobacterium30. Besides, sev-
eral studies have shown that IL-22 participates in the protective
immunity against tuberculosis28,31,32. Taken together, our findings
indicate that rs2227473 polymorphism controls IL-22 response upon
Mycobacterium tuberculosis infection, which in turn determines, at
least in part, the outcome of infection.
In summary, our study demonstrates an association between poly-
morphisms in the promoter of IL-22 gene and TB susceptibility. The
rs2227473 polymorphism and associated SNPs in the promoter
region of the IL-22 gene are associated with decreased susceptibility
to pulmonary TB in Chinese. The ‘TGTAG’ haplotype, which pre-
sents in 45.6% of the Chinese population, is associated with increased
susceptibility to TB. The rs2227473 polymorphism affects IL-22’s
protein expression. Our SNP selection strategy focusing on regula-
tory SNPs is effective in identifying susceptive loci for the IL22 gene.
Methods
Subjects and samples. Patients with different manifestations of active TB were
recruited at clinics in the Shenzhen Third People’s Hospital and Shenzhen
Polytechnic College in Shenzhen, China. Healthy adults with no history of TB disease
were also recruited as the control group. All participants had received bacillus
Calmette-Gue´rin (BCG) vaccination at birth.We usedM. tuberculosis-specific IFN-c
enzyme-linked immunospot (ELISPOT) assay to exclude LTBI from healthy donors,
and only thosewhowere ELISPOTnegative were selected as our healthy controls. The
diagnosis of tuberculosis was based on mycobacterium tuberculosis examination,
clinical symptoms, and chest X-ray examination as described before13. Samples
collected before Feb., 2010 were used as our experimental cohort (479 cases and 358
controls) and samples collected after that date were used as our validation cohort (413
cases and 241 controls). The statistics of age distributions and male/female ratios are
listed in Supplementary Table S3. The study obtained ethical approval from the
Institutional Review Board of the Shenzhen Third People’s Hospital, and informed
written consent was obtained from all the patients. Clinical specimens from patients
with TB were collected within one week after anti-TB treatment. Whole blood was
collected by venipuncture from the populations mentioned above.
Table 3 | Association of TB susceptibility and IL22 haplotypes and in the pooled study in Chinese (479 cases and 358 controls)
Haplotype id Code* Haplotype{ Frequency
Frequencies
OR
95% CI
P-value{Cases Controls LCL UCL
H1 mmmmm CTCAA 0.09 0.08 0.11 0.75 0.52 1.07 0.11
H2 mmMmm CTTAA 0.01 0.004 0.03 0.04 0.01 0.35 2.12E-06
H3 mmmMm CTCGA 0.07 0.07 0.07 1.19 0.70 2.02 0.68
H4 mmMMm CTTGA 0.32 0.31 0.32 1.32 0.92 1.90 0.69
H5 MMMMM TATGG 0.49 0.52 0.46 1.49 1.05 2.13 0.01
*M refers to major allele, and m refers to minor allele. {SNPs are in the order of (rs2227485, rs2227483, rs2227478, rs2227473, and rs2227472). {current haplotype against the rest.
Table 4 | TB susceptibility and polymorphism of IL-22 in the pooled data analysis of association studies for different age groups of Chinese
Age
Sample counts
SNP id
MAF
Minor allele OR
95% CI
P-valueCases Controls Cases Controls LCL UCL
# 25 147 95 rs2227472 0.386 0.572 A 0.469 0.313 0.703 2.2E-04
rs2227473 0.120 0.169 A 0.669 0.376 1.192 0.171
rs2227478 0.166 0.209 C 0.751 0.466 1.211 0.240
rs2227483 0.393 0.566 T 0.496 0.313 0.785 2.6E-03
rs2227485 0.389 0.586 C 0.448 0.303 0.663 5.2E-05
. 25 332 263 rs2227472 0.502 0.496 G 1.025 0.802 1.309 0.8459
rs2227473 0.088 0.134 A 0.624 0.417 0.624 0.0208
rs2227478 0.141 0.185 C 0.724 0.528 0.991 0.0435
rs2227483 0.486 0.515 T 0.892 0.680 1.169 0.4069
rs2227485 0.500 0.492 C 1.034 0.813 1.315 0.7877
www.nature.com/scientificreports
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SNP selection. Since we focus on the SNPs with regulatory roles, we are particularly
interested in two types of SNPs: (a) the SNP that is in a putative transcription factor
binding site, and its two alleles that alter the binding scores, and (b) the SNP that is in a
putative microRNA target site and the two alleles that alter the miRNA-target
interaction scores.
To search for the SNPs with alleles that alter the putative transcription factor
binding sites, we scanned the promoter region of the gene with annotated Position
WeightMatrices (PWMs) in Jaspar33, UniPROBE34 and TRANSFAC35 databases. We
first obtained the gene coordinates (txStart and txEnd) for human genome hg18
(NCBI36) from the RefSeq table of UCSC table browser (http://genome.ucsc.edu/).
For the annotated SNPs in dbSNP129 that are within 2000 bp upstream to 500 bp
downstream of the IL-22 gene, we extracted their flanking sequence (1-25bp) from
the dbSNP website (http://www.ncbi.nlm.nih.gov/projects/SNP/). For each SNP, we
kept the flanking sequence the same and changed the alleles, thus obtaining one
sequence for each allele and forming a sequence set. We then used a PWM_SCAN
algorithm36 to scan each sequence in the set to test whether it had a putative binding
site (PBS), with the method we described in37. We considered sites with a probability
score of p-value,50.001 as PBS. If the SNP was within the PBS and any of the two
alleles had differential p-values, we calculated the ratio (Sr) of p-values by dividing the
bigger p-value by the smaller p-value. The Sr measures how the two alleles in the PBS
change the binding scores between the PBS and putative binding protein. We then
converted this Sr into a p-value based on a background distribution from a per-
mutation test, based on the FastPval program38. If an SNP has Sr with p-value, 0.01,
we considered this SNP as functional and thus selected it for genotyping.
To search for the SNPs with alleles that alter the putativemicroRNA target sites, we
first searched the PITA database for the microRNAs that could target the 39 UTR
region of the IL-22 gene. For the SNP that is in the target site, we obtained its flanking
sequence (1-50bp) from the UCSC genome browser according to its genomic loca-
tion. We then changed the polymorphism site and obtained one sequence for each of
the alleles. First, we tested whether the change of alleles also changed the microRNA-
target interaction by RNAhybrid. The RNAhybrid calculates the minimum hybrid-
ization energy between the microRNA and its target. If the alleles in the polymorphic
site change this energy significantly, it might enhance or repress the regulatory
function of the RNA, and thus plays a role in the disease. Second, we used RNAfold to
calculate the thermodynamics of the putative target site. If the alleles change the
thermodynamics of the target, this might affect the chance of the microRNA binding
to its target, and thus affect the function of the microRNA. SNPs with statistical
significance in either target thermodynamics or microRNA-target interaction were
selected for genotyping.
In addition to the regulatory SNPs, we also used the traditional tagging procedure
to select SNPs that cover the IL-22 gene39. We chose the CHB1JPT HapMap panel,
included our regulatory SNPs, chose r2 50.8 and used default settings for all other
parameters. We also selected SNPs in the IL-22 gene region that are reported to be
associated with disease. The functional, tagged, and selected SNPs are shown in
Supplementary Table S4. The consensuses of the putative binding sites of each
selected SNP are shown in Supplementary Table S2.
SNP genotyping. Genomic DNA was extracted with a DNA isolation kit (Qiagen
Inc., Germany), following themanufacturer’s instruction. SNPs were typed by a high-
throughput SequenomH genotyping platform (San Diego, CA, USA). The genotypes
were determined by a Homogenous Mass EXTEND assay. The Mass ARRAY
AssayDesign software was used to design allele-specific extension primers. The
primers designed for each selected SNP are listed in Supplementary Table S5. The
genotyping for the experimental cohort was carried out in Shenzhen, and genotyping
for the validation cohort was carried out in both Shenzhen and Hong Kong, with
concordance .98%.
Statistical analysis. We used PLINK v1.07 and Haploview v4.0 for all the analysis
undertaken. At each stage, SNPs that failed the Hardy-Weinburg equilibrium (p-
value, 0.05) were removed from further analysis. We used allelic association tests to
compare the frequency of SNP alleles in cases and controls. OR and 95% CI were
estimated using logistic regression models. We performed allelic association tests for
different age groups (,525 and.25). The haplotype association test was performed
in the region surrounding the rs2227473 marker. SNPs or haplotypes with p-values
, 0.05 were considered to be significant.
Quantifications of IL-22 under specific and non-specific stimuli of PBMCs. 5ml
peripheral blood samples of TB patients were collected and PBMCs were isolated by
the Ficoll lymphocyte separation medium. PBMCs were then spread into a 96-well
plate at the cell density of 43105, and 1ug/ml of monoclonal antibodies anti-CD3 and
anti-CD28 were added for non-specific stimulation, and 20ug/ml of Mycobacterium
tuberculosis (Mtb) lysate were added for specific stimulation. The stimulated PBMCs
were incubated at 37uC, 5% CO2 for 96h. Cell supernatants were used for IL-22
protein quantification with ELISA.
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